COMPASS Patent Highlights Importance of Crystallography in Psychedelic Drug Development
The scope and validity of this patent will depend on how x-ray diffraction data is interpreted.
Articles - Page 27
Placebo-Controlled Study Finds Psilocybin Formulation is Safe and Well-Tolerated in Healthy Volunteers
The study used an investigational psilocybin formulation called COMP360 developed and produced by COMPASS Pathways.
Study Identifies Compounds and Mechanism that Causes Psilocybin Mushroom Bluing
These bluing compounds can exist as dimeric, trimeric, and tetrameric forms of psilocin and/or its structural analogs.
Altered Oscillations: The Modulatory Effect of DMT on Brain Waves
A recent Nature paper provides novel insights into the neural correlates of the Breakthrough Experience associated with DMT.
Study Finds ALD-52, 1P-LSD, and 1B-LSD Are Prodrugs of LSD
Identifying and understanding prodrugs is an essential component of psychedelic drug research.
New Zealand’s Ministry of Health Approves LSD Microdosing Study
The study will examine the effects of microdosing LSD on the everyday lives of the participants.
Denver Mayor Creates Psilocybin Mushroom Policy Review Panel
Coming on the heels of the passing of their magic mushroom decriminalization measure in May, the city of Denver, Colorado has created the world’s first Psilocybin Mushroom Policy Review Panel...
Machine Intervention: Psychedelics, Artificial Intelligence, and the Drug Discovery Process
A look into the promising potential of artificial intelligence in tackling unmet medical needs in mental healthcare
Understanding Ego Death’s Neurobiology
Psychedelics disrupt the brain networks responsible for the feeling of selfhood.
Scientists Solve the Crystal Structure of the Psilocbyin Derviative 4-HO-DPT
This new crystal form presents new options for developing psychedelics into therapeutic drug formulations.